Keep calm and carry on-managing non-TNF antagonist biologics in pregnancy

Cynthia H Seow^{1

2}, Christopher Ma^{1

2}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
² Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

Editorial

Cynthia H Seow et al. Aliment Pharmacol Ther. 2021 Feb.

. 2021 Feb;53(3):450-451.

doi: 10.1111/apt.16207.

Cynthia H Seow^{1

2}, Christopher Ma^{1

2}

¹ Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
² Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

No abstract available

Comment in

Editorial: keep calm and carry on-managing non-TNF antagonist biologics in pregnancy-authors' reply.
Wils P, Pariente B. Wils P, et al. Aliment Pharmacol Ther. 2021 Feb;53(3):452-453. doi: 10.1111/apt.16230. Aliment Pharmacol Ther. 2021. PMID: 33428252 No abstract available.

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study.
Wils P, Seksik P, Stefanescu C, Nancey S, Allez M, Pineton de Chambrun G, Altwegg R, Gilletta C, Vuitton L, Viennot S, Serrero M, Fumery M, Savoye G, Collins M, Goutorbe F, Brixi H, Bouguen G, Tavernier N, Boualit M, Amiot A, Abitbol V, Laharie D, Pariente B; PREGNANCY-GETAID study group. Wils P, et al. Aliment Pharmacol Ther. 2021 Feb;53(4):460-470. doi: 10.1111/apt.16192. Epub 2020 Dec 7. Aliment Pharmacol Ther. 2021. PMID: 33345331

1. Kaye DK. The moral imperative to approve pregnant women’s participation in randomized clinical trials for pregnancy and newborn complications. Philos Ethics, Humanit Med. 2019;14:1-11.
1. Windsor JW, Kaplan GG. Evolving epidemiology of IBD. Curr Gastroenterol Rep. 2019;21. https://doi.org/10.1007/s11894-019-0705-6
1. Nguyen GC, Seow CH, Maxwell C, et al. The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology. 2016;150:734-757.e1. https://doi.org/10.1053/j.gastro.2015.12.003
1. Leung KK, Tandon P, Govardhanam V, Maxwell C, Huang V. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2020:1-13. https://doi.org/10.1093/ibd/izaa122
1. Kim M-A, Kim Y-H, Chun J, et al. The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2020. jjaa225, https://doi.org/10.1093/ecco-jcc/jjaa225 Online ahead print